4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-012541
CHIEF MEDICAL OFFICER sold 200 shares at $27.00 ($5,400)
- CHIEF MEDICAL OFFICER acquired 200 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paolini John F. CHIEF MEDICAL OFFICER | 2025-05-07 | Option exercise 10b5-1 | +200 | $3.80 | $760 | 57,603 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2025-05-07 | Sale 10b5-1 | −200 | $27.00 | $5,400 | 57,403 | D |
| Derivatives | |||||||
| Paolini John F. CHIEF MEDICAL OFFICER | 2025-05-07 | Option exercise · Share Option 10b5-1 | −200 | 65,867 | D | ||
| Open-market sales · 200 sh · avg $27.00 · $5,400 | |||||||
Loading xslF345X05/form4-05092025_090502.xml…